These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 28258008)

  • 1. High-content screening of clinically tested anticancer drugs identifies novel inhibitors of human MRP1 (ABCC1).
    Peterson BG; Tan KW; Osa-Andrews B; Iram SH
    Pharmacol Res; 2017 May; 119():313-326. PubMed ID: 28258008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin as a fluorescent reporter identifies novel MRP1 (ABCC1) inhibitors missed by calcein-based high content screening of anticancer agents.
    Sampson A; Peterson BG; Tan KW; Iram SH
    Biomed Pharmacother; 2019 Oct; 118():109289. PubMed ID: 31401398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput screening identifies Ceefourin 1 and Ceefourin 2 as highly selective inhibitors of multidrug resistance protein 4 (MRP4).
    Cheung L; Flemming CL; Watt F; Masada N; Yu DM; Huynh T; Conseil G; Tivnan A; Polinsky A; Gudkov AV; Munoz MA; Vishvanath A; Cooper DM; Henderson MJ; Cole SP; Fletcher JI; Haber M; Norris MD
    Biochem Pharmacol; 2014 Sep; 91(1):97-108. PubMed ID: 24973542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of new MRP4 inhibitors from a library of FDA approved drugs using a high-throughput bioluminescence screen.
    Cheung L; Yu DM; Neiron Z; Failes TW; Arndt GM; Fletcher JI
    Biochem Pharmacol; 2015 Feb; 93(3):380-8. PubMed ID: 25462817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
    To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
    J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development.
    Zhou SF; Wang LL; Di YM; Xue CC; Duan W; Li CG; Li Y
    Curr Med Chem; 2008; 15(20):1981-2039. PubMed ID: 18691054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhinacanthin-C enhances doxorubicin cytotoxicity via inhibiting the functions of P-glycoprotein and MRP2 in breast cancer cells.
    Chaisit T; Siripong P; Jianmongkol S
    Eur J Pharmacol; 2017 Jan; 795():50-57. PubMed ID: 27916559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcitriol and Calcipotriol Modulate Transport Activity of ABC Transporters and Exhibit Selective Cytotoxicity in MRP1-overexpressing Cells.
    Tan KW; Sampson A; Osa-Andrews B; Iram SH
    Drug Metab Dispos; 2018 Dec; 46(12):1856-1866. PubMed ID: 30232176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collateral sensitivity of resistant MRP1-overexpressing cells to flavonoids and derivatives through GSH efflux.
    Lorendeau D; Dury L; Genoux-Bastide E; Lecerf-Schmidt F; Simões-Pires C; Carrupt PA; Terreux R; Magnard S; Di Pietro A; Boumendjel A; Baubichon-Cortay H
    Biochem Pharmacol; 2014 Aug; 90(3):235-45. PubMed ID: 24875445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrrolopyrimidine derivatives and purine analogs as novel activators of Multidrug Resistance-associated Protein 1 (MRP1, ABCC1).
    Schmitt SM; Stefan K; Wiese M
    Biochim Biophys Acta Biomembr; 2017 Jan; 1859(1):69-79. PubMed ID: 27810353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lapatinib antagonizes multidrug resistance-associated protein 1-mediated multidrug resistance by inhibiting its transport function.
    Ma SL; Hu YP; Wang F; Huang ZC; Chen YF; Wang XK; Fu LW
    Mol Med; 2014 Sep; 20(1):390-9. PubMed ID: 25105301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vatalanib sensitizes ABCB1 and ABCG2-overexpressing multidrug resistant colon cancer cells to chemotherapy under hypoxia.
    To KK; Poon DC; Wei Y; Wang F; Lin G; Fu LW
    Biochem Pharmacol; 2015 Sep; 97(1):27-37. PubMed ID: 26206183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterocyclic cyclohexanone monocarbonyl analogs of curcumin can inhibit the activity of ATP-binding cassette transporters in cancer multidrug resistance.
    Revalde JL; Li Y; Hawkins BC; Rosengren RJ; Paxton JW
    Biochem Pharmacol; 2015 Feb; 93(3):305-17. PubMed ID: 25543853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulators of multidrug resistance associated proteins in the management of anticancer and antimicrobial drug resistance and the treatment of inflammatory diseases.
    Yang AK; Zhou ZW; Wei MQ; Liu JP; Zhou SF
    Curr Top Med Chem; 2010; 10(17):1732-56. PubMed ID: 20645920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug-resistant tumor cells remain sensitive to a recombinant interleukin-4-Pseudomonas exotoxin, except when overexpressing the multidrug resistance protein MRP1.
    de Jong MC; Scheffer GL; Broxterman HJ; Hooijberg JH; Slootstra JW; Meloen RH; Kreitman RJ; Husain SR; Joshi BH; Puri RK; Scheper RJ
    Clin Cancer Res; 2003 Oct; 9(13):5009-17. PubMed ID: 14581376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput flow cytometry to detect selective inhibitors of ABCB1, ABCC1, and ABCG2 transporters.
    Ivnitski-Steele I; Larson RS; Lovato DM; Khawaja HM; Winter SS; Oprea TI; Sklar LA; Edwards BS
    Assay Drug Dev Technol; 2008 Apr; 6(2):263-76. PubMed ID: 18205550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrrolopyrimidine Derivatives as Novel Inhibitors of Multidrug Resistance-Associated Protein 1 (MRP1, ABCC1).
    Schmitt SM; Stefan K; Wiese M
    J Med Chem; 2016 Apr; 59(7):3018-33. PubMed ID: 26943020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro, in vivo and ex vivo characterization of ibrutinib: a potent inhibitor of the efflux function of the transporter MRP1.
    Zhang H; Patel A; Ma SL; Li XJ; Zhang YK; Yang PQ; Kathawala RJ; Wang YJ; Anreddy N; Fu LW; Chen ZS
    Br J Pharmacol; 2014 Dec; 171(24):5845-57. PubMed ID: 25164592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wogonin reverses multi-drug resistance of human myelogenous leukemia K562/A02 cells via downregulation of MRP1 expression by inhibiting Nrf2/ARE signaling pathway.
    Xu X; Zhang Y; Li W; Miao H; Zhang H; Zhou Y; Li Z; You Q; Zhao L; Guo Q
    Biochem Pharmacol; 2014 Nov; 92(2):220-34. PubMed ID: 25264278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.